Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 127 articles:
HTML format
Text format



Single Articles


    May 2018
  1. RAGGI P
    Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
    Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
    PubMed     Text format    


    April 2018
  2. MACEDONI M, Hovnik T, Plesnik E, Kotnik P, et al
    Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes.
    Atherosclerosis. 2018;273:53-58.
    PubMed     Text format     Abstract available


    March 2018
  3. SUAREZ-ORTEGON MF, McLachlan S, Price AH, Fernandez-Balsells M, et al
    Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.
    Atherosclerosis. 2018;272:193-199.
    PubMed     Text format     Abstract available


  4. AL-SHAREA A, Murphy AJ, Huggins LA, Hu Y, et al
    SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr(-/-) type 1 diabetic mice.
    Atherosclerosis. 2018;271:166-176.
    PubMed     Text format     Abstract available


  5. SINIARSKI A, Haberka M, Mostowik M, Golebiowska-Wiatrak R, et al
    Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Atherosclerosis. 2018;271:148-155.
    PubMed     Text format     Abstract available


    February 2018
  6. RAGGI P
    Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
    Atherosclerosis. 2018;271:77-83.
    PubMed     Text format     Abstract available


    December 2017
  7. LIGHTELL DJ JR, Moss SC, Woods TC
    Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus.
    Atherosclerosis. 2017;269:71-78.
    PubMed     Text format     Abstract available


  8. TORRES-PENA JD, Garcia-Rios A, Delgado-Casado N, Gomez-Luna P, et al
    Mediterranean diet improves endothelial function in patients with diabetes and prediabetes: A report from the CORDIOPREV study.
    Atherosclerosis. 2017;269:50-56.
    PubMed     Text format     Abstract available


    November 2017
  9. CHRISTODOULOU E, Kadoglou NPE, Stasinopoulou M, Konstandi OA, et al
    Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
    Atherosclerosis. 2017 Nov 1. pii: S0021-9150(17)31370.
    PubMed     Text format     Abstract available


    October 2017
  10. GANJALI S, Dallinga-Thie GM, Simental-Mendia LE, Banach M, et al
    HDL functionality in type 1 diabetes.
    Atherosclerosis. 2017;267:99-109.
    PubMed     Text format     Abstract available


    September 2017
  11. MARCADENTI A, Fuchs FD, Moreira LB, Gus M, et al
    Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.
    Atherosclerosis. 2017;266:145-150.
    PubMed     Text format     Abstract available


    August 2017
  12. TAMURA K, Haruhara K, Azushima K, Tokita Y, et al
    Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes.
    Atherosclerosis. 2017 Aug 26. pii: S0021-9150(17)31240.
    PubMed     Text format    


  13. CHU LM, Liu CC, Yeh CC, Chang YC, et al
    Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies.
    Atherosclerosis. 2017;265:87-92.
    PubMed     Text format     Abstract available


  14. SCHMIDT N, Schmidt B, Dressel A, Gergei I, et al
    Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Atherosclerosis. 2017;266:24-30.
    PubMed     Text format     Abstract available


  15. CAMARGO GARCIA A, Garcia-Carpintero S, Lopez-Moreno J, Jimenez-Lucena R, et al
    Postprandial endotoxemia may influence the type 2 diabetes mellitus development.
    Atherosclerosis. 2017;263:e98.
    PubMed     Text format    


  16. STECHOVA K, Sklenarova J, Kratzerova T, Filipp D, et al
    Association between immune and lipid factors in women with diabetes type 1.
    Atherosclerosis. 2017;263:e97-e98.
    PubMed     Text format    


  17. EL KHOURY P, Roussel R, Fumeron F, Velho G, et al
    Plasma PCSK9 and cardiovascular events in type 2 diabetes.
    Atherosclerosis. 2017;263:e81.
    PubMed     Text format    


  18. WITKOWSKI M, Weithauser A, Tabaraie T, Steffens D, et al
    Endothelial micrornas epigenetically control vascular inflammation and thrombogenicity in diabetes.
    Atherosclerosis. 2017;263:e76.
    PubMed     Text format    


  19. SUN Y, Kopp S, Gali CC, Zandl M, et al
    Gestational diabetes mellitus modulates cholesterol metabolism in human fetoplacental endothelial cells.
    Atherosclerosis. 2017;263:e74-e75.
    PubMed     Text format    


  20. WALUS-MIARKA M, Idzior-Walus B, Trojak A, Kapusta M, et al
    Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    


  21. PITHOVA P, Pitha J, Stechova K, Kvapil M, et al
    Preclinical atherosclerosis is associated with insulin resistance in type 1 diabetes women.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    


  22. IHM SH, Lee KY, Kim JJ, Hwang BH, et al
    CT Angiography-imaged coronary artery stenosis provides better risk prediction than traditional risk factors in asymptomatic diabetic individuals: A long-term study of clinical outcomes.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    


  23. ILYAS Z, Al-Ghamdi J, Nguan-Soon T, Kiss-Toth E, et al
    Tribbles-3, a regulator of metabolic syndromes and type 2 diabetes.
    Atherosclerosis. 2017;263:e50.
    PubMed     Text format    


  24. CAVALCANTE MARANHAO R, Franca Marques A, Guido MC, Rufo Tavares E, et al
    Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats.
    Atherosclerosis. 2017;263:e48.
    PubMed     Text format    


  25. STOJIC I, Tepic S, Petkovic A, Srejovic I, et al
    Time dependent effects of hbot on redox status in diabetic patients.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    


  26. MANEA V, Pop C, Pop L
    Correlations of dipper profiles in diabetic patients with hypertension: the importance of ambulatory blood pressure monitoring/24 hours.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    


  27. KYRIAZIS I, Sgouros K, Stefani D, Vallianou K, et al
    The effect of the presence and the level of dyslipidemia control on diabetic patients with first acute ischemic stroke.
    Atherosclerosis. 2017;263:e275-e276.
    PubMed     Text format    


  28. PITHA J, Pithova P, Roztocil K, Urbaniec K, et al
    Oliva-roztocil index, specific parameter of vascular damage in women suffering from diabetes mellitus.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    


  29. KUMAR N, Khanna RK
    Anti-diabetic effect of trigonella foenum greacum seed acetone fraction in a type 2 diabetes model of rats.
    Atherosclerosis. 2017;263:e273.
    PubMed     Text format    


  30. BAUDIN B, Nekaies Y, Baudin B, Kelbousi S, et al
    Association of apolipoproteins plasma levels with PCSK9 in type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e273-e274.
    PubMed     Text format    


  31. RAJPUT S, Sinha S
    Modulation of the coexistence of diabetes and hypothyroidism on body weight gain, leptin and various metabolic aspects in wistar rats.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    


  32. DIOSZEGI A, Vass M, Nemeth N, Sogor V, et al
    Rheopheresis treatment of diabetic foot syndrome.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    


  33. NANASY-VASS M, Dioszegi A, Flasko A, Mechler F, et al
    Study of microcirculatory impairment in type 2 diabetic patients with symptoms of peripherial neuropathy.
    Atherosclerosis. 2017;263:e272-e273.
    PubMed     Text format    


  34. SHALAEVA E, Janabaev B, Bobabekov A, Kasimov U, et al
    Coronary computed tomographic angiography and coronary artery calcium score in patients with type 2 diabetes undergoing trans-femoral amputation in 2013 in different clinical groups.
    Atherosclerosis. 2017;263:e271-e272.
    PubMed     Text format    


  35. ENA J, Perez S, Alvarez CE, Valls V, et al
    Triglyceride to high density lipoprotein cholesterol ratio, total cholesterol to high density lipoprotein cholesterol ratio and low ankle brachial index in patients with diabetes.
    Atherosclerosis. 2017;263:e270.
    PubMed     Text format    


  36. ENA J, Perez S, Argente CR, Lozano T, et al
    Systolic blood pressure difference between arms and peripheral arterial disease in patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e270-e271.
    PubMed     Text format    


  37. ZIVKOVIC V, Vranic A, Simovic S, Ristic P, et al
    The acute effects of different spironolactone doses on cardiac function in streptozotocine-induced diabetic rats.
    Atherosclerosis. 2017;263:e268-e270.
    PubMed     Text format    


  38. DUARTE JS, Bello C, Ferreira R, Limbert C, et al
    Atherogenic dislipidemia in patients with type 2 diabetes linked to microvascular complications and heart disease.
    Atherosclerosis. 2017;263:e265.
    PubMed     Text format    


  39. ZHILINA S, Miramontes Gonzalez JP, Laso Guzman FJ
    Familial hypercholesterolemia and the diabetogenic effect of statins.
    Atherosclerosis. 2017;263:e264.
    PubMed     Text format    


  40. BENEDI MVM, Calahorra SP, Sanz AMB, Baila Rueda L, et al
    A randomized, open-label study to investigate the effect of a high protein diet compared to a normoprotein diet on hydrocarbon metabolism in patients with diabetes or prediabetes and obesity.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    


  41. NIKOLOVA A, Milanova M, Stoyanov K, Yankov G, et al
    Risk assessment for diabetes mellitus type 2 in women.
    Atherosclerosis. 2017;263:e263-e264.
    PubMed     Text format    


  42. SZTANEK F, Seres I, Lorincz H, Molnar A, et al
    Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with diabetic neuropathy.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    


  43. CASULA M, Mozzanica F, Scotti L, Tragni E, et al
    Statin use and risk of new-onset diabetes: a meta-analysis of observational studies.
    Atherosclerosis. 2017;263:e262-e263.
    PubMed     Text format    


  44. DOULAMIS I, Tzani A, Konstantopoulos P, Antoranz A, et al
    Targeted proteomics identification of biomarkers for diabetes mellitus in patients with cardiovascular disease.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    


  45. PARAGH G, Lorincz H, Somodi S, Varga VE, et al
    Serum afamin level is strongly associated to the components of metabolic syndrome in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    


  46. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Ragino Y, et al
    The prevalence of dyslipidemia in young patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e260-e261.
    PubMed     Text format    


  47. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Voevoda M, et al
    Clinical case: The development of atherosclerosis in a patient 28 years old with 12 mody diabetes.
    Atherosclerosis. 2017;263:e260.
    PubMed     Text format    


  48. BARKAS F, Elisaf M, Liberopoulos E, Liamis G, et al
    Metabolic markers to predict incident diabetes in statin-treated individuals.
    Atherosclerosis. 2017;263:e259.
    PubMed     Text format    


  49. SHAKHTSHNEIDER E, Ovsyannikova A, Ivanoshchuk D, Rymar O, et al
    The spectrum of mutations in the CEL gene in early onset diabetes patients.
    Atherosclerosis. 2017;263:e259-e260.
    PubMed     Text format    


  50. GARCIA-DONAIRE JA, Franch-Nadal J, Rodriguez-Fortunez P, Labrador-Barba E, et al
    The importance of the training as an integral part of caring for the diabetic patient. FORMA2 study: Differences between urban and rural work area.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    


  51. SHALIMOVA A, Bilovol O, Bobronnikova L
    Severity of cardiovascular remodeling in comorbidity of essential hypertension and type 2 diabetes depending on genetic polymorphism of AGTR1 and IRS-1.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    


  52. HAN Y, Jang YN, Lee YJ, Kim HM, et al
    Fimasartan nomalizes carbohydrate metabolism through AMPK pathway in diabetic condition.
    Atherosclerosis. 2017;263:e258-e259.
    PubMed     Text format    


  53. VONBANK A, Zanolin D, Leiherer A, Rein P, et al
    The power of thyroid stimulating hormone to predict cardiovascular mortality in non-obese patients is significantly modulated by type 2 diabetes.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  54. SAELY C, Vonbank A, Zanolin D, Leiherer A, et al
    Single and joint effects of obesity and of the metabolic syndrome on the development of diabetes in patients with coronary atherosclerosis.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  55. SAELY C, Rein P, Leiherer A, Vonbank A, et al
    Remnant cholesterol predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  56. SAELY C, Zanolin D, Rein P, Leiherer A, et al
    Concordance of glucose-based and of HbA1c-based diagnoses of diabetes in patients with peripheral arterial disease-a comparison between men and women.
    Atherosclerosis. 2017;263:e255.
    PubMed     Text format    


  57. SAELY C, Zanolin D, Vonbank A, Leiherer A, et al
    Non-alcoholic fatty liver disease strongly predicts incident diabetes in patients with coronary artery disease.
    Atherosclerosis. 2017;263:e255-e256.
    PubMed     Text format    


  58. DEMIKHOVA N, Chernatska O, Smiianova O, Vynnychenko L, et al
    The correlation between polimorphism of CYP7a1 gene and glycated hemoglobin in hypertensive patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    


  59. KIM BJ, Han JM, Do JH, Kim BS, et al
    Sex-specific relationship between cotinine-verified second-hand smoke exposure and diabetes in 85,697 never-smokers.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    


  60. EISENGA M, Zelle D, Sloan J, Gaillard C, et al
    High serum PCSK9 is associated with increased risk of new-onset diabetes after transplantation in renal transplant recipients.
    Atherosclerosis. 2017;263:e254-e255.
    PubMed     Text format    


  61. MITSUTAKE R
    Effect of canagliflozin on visceral fat area and heart rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e252.
    PubMed     Text format    


  62. FULOP P, Seres I, Lorincz H, Somodi S, et al
    Lipocalin 2 may be a potential biomarker of atherosclerotic complications in obese non-diabetic individuals.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    


  63. SZENTPETERI A, Lorincz H, Somodi S, Varga VE, et al
    Human obestatin level and its correlations with metabolic syndrome components in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    


  64. KARASEK D, Gajdova J, Kubickova V, Krystynik O, et al
    Selected adipokines in patients with type 2 diabetes: Relationship to soluble markers of endothelial dysfunction-a pilot study.
    Atherosclerosis. 2017;263:e249.
    PubMed     Text format    


  65. ASKRI I, Kelbousi S, Sakly M, Attia N, et al
    Atorvastatin effect on phospholipid profile and distribution between lipoprotein fractions in type 2 diabetic patients with and without CAD.
    Atherosclerosis. 2017;263:e246.
    PubMed     Text format    


  66. YASUDA H, Fujiwara A, Komiya S, Haze T, et al
    Effects of rosuvastatin add-on treatment on hyperlipidemia in type 2 diabetic patients with chronic kidney disease receiving ethyl icosapentate.
    Atherosclerosis. 2017;263:e241-e242.
    PubMed     Text format    


  67. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    


  68. MAGLAPHERIDZE Z, Tabukashvili R, Kapetivadze V, Tchaava K, et al
    Treatment of dyslipidemia in diabetic type 2 patients with hypertension.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    


  69. MARANHAO RC, Tavoni TM, Laverdy Neto OG, Sprandel MDCO, et al
    Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    


  70. ARAGONA CO, Cairo V, Scuruchi M, Giunta L, et al
    Evaluation of Lp(a) and insulin during pregnancy in not diabetic women. Preliminary data.
    Atherosclerosis. 2017;263:e208.
    PubMed     Text format    


  71. WALUS-MIARKA M, Trojak A, Kapusta M, Idzior-Walus B, et al
    Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes.
    Atherosclerosis. 2017;263:e207.
    PubMed     Text format    


  72. VASILKOVA V, Mokhort T, Naumenko E, Zmailik M, et al
    Association between systolic dysfunction and inflammation in diabetic patients with chronic kidney disease.
    Atherosclerosis. 2017;263:e191.
    PubMed     Text format    


  73. LAKHOUA Y, Ben Nacef I, Bouzid K, M'Chrirgui N, et al
    Prevalence of diabetes and frequency of cardiovascular risk factors in paramedical and administrative staff of Charles Nicolle hospital.
    Atherosclerosis. 2017;263:e180-e181.
    PubMed     Text format    


  74. VONBANK A, Saely C, Rein P, Leiherer A, et al
    The visceral adiposity index predicts cardiovascular events both in coronary artery disease patients with and in coronary artery disease patients without diabetes.
    Atherosclerosis. 2017;263:e172-e173.
    PubMed     Text format    


  75. VIKULOVA O, Bolotskaya L, Bessmertnaya E, Artemova E, et al
    Frequency of diabetic complications and HbA1C level by active screening and diabetes registry data: Comparative study.
    Atherosclerosis. 2017;263:e171.
    PubMed     Text format    


  76. KONSTANTOPOULOS P, Tzani A, Doulamis IP, Korou ML, et al
    Anti-inflammatory, hypolipidemic and hepatoprotective properies of CMG in an experimental model of diabetes.
    Atherosclerosis. 2017;263:e166-e167.
    PubMed     Text format    


  77. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    The role of physical training on neuroendocrine axis, physiology and metabolism in elderly with/without diabetes.
    Atherosclerosis. 2017;263:e161.
    PubMed     Text format    


  78. KUMAR S, Sharma V
    Hypertension, obesity, diabetes, and heart failure-free survival: The cardiovascular disease lifetime risk pooling project in New Delhi, India.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    


  79. NOVAKOVIC R, Cirovic S, Markovic-Lipkovski J, Rajkovic J, et al
    Effect of polyphenol resveratrol on the isolated renal artery of normal and diabetic rats.
    Atherosclerosis. 2017;263:e157.
    PubMed     Text format    


  80. STOJANOVIC M, Radenkovic M
    Clarification of serotonin-induced effects in peripheral artery disease via the rat femoral artery response in models of diabetes and vascular occlusion.
    Atherosclerosis. 2017;263:e133-e134.
    PubMed     Text format    


  81. RAJKOVIC J, Peric M, Stanisic J, Rakocevic J, et al
    Involvement of ATP-sensitive potassium channels in effect of pinacidil on saphenous vein obtained from the patients with and without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e131.
    PubMed     Text format    


  82. NIKOLOV A, Tsinlikov I, Tsinlikova I, Nicoloff G, et al
    Levels of anti-elastin IgA antibodies are associated with high risk of atherosclerosis in diabetics with essential hypertension.
    Atherosclerosis. 2017;263:e124-e125.
    PubMed     Text format    


  83. MELNIKOV I, Gabbasov Z, Kozlov S, Byazrova S, et al
    Assessment of novel biomarkers for restenosis occurrence after drug-eluting stent implantation in patients with stable coronary artery disease and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e121-e122.
    PubMed     Text format    


  84. VIRTA J, Silvola J, Hellberg S, Stahle M, et al
    Effects of linagliptin intervention on atherosclerotic plaque inflammation and 18F-FDG uptake in a mouse model of type 2 diabetes.
    Atherosclerosis. 2017;263:e119-e120.
    PubMed     Text format    


  85. PETELINA T, Musikhina N, Gapon L, Emeneva I, et al
    Features of atherogenic lipid profile and inflammatory markers in patients with stable angina and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    


  86. KULIKOWSKI E, Calosing C, Tsujikawa L, Wasiak S, et al
    Apabetalone (RVX-208) may lower CVD events in diabetes mellitus by affecting complement pathway and microbiome activity.
    Atherosclerosis. 2017;263:e113.
    PubMed     Text format    


  87. POVLSEN GK, Langhi C, Skytte Olsen G
    Regulation of hepatic LDL-receptor and PCSK9 expression by insulin in diabetic mice and in vitro in hepatocyte models.
    Atherosclerosis. 2017;263:e102.
    PubMed     Text format    


    July 2017
  88. ESTRUCH M, Minambres I, Sanchez-Quesada JL, Soler M, et al
    Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients.
    Atherosclerosis. 2017 Jul 13. pii: S0021-9150(17)31190.
    PubMed     Text format     Abstract available


  89. PRICE AH, Weir CJ, Welsh P, McLachlan S, et al
    Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
    Atherosclerosis. 2017;264:67-73.
    PubMed     Text format     Abstract available


  90. WANNAMETHEE SG, Welsh P, Papacosta O, Ellins EA, et al
    Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.
    Atherosclerosis. 2017;264:36-43.
    PubMed     Text format     Abstract available


    June 2017
  91. HAGENSEN MK, Mortensen MB, Kjolby M, Stillits NL, et al
    Reply to "Bioinformatics analysis in type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta".
    Atherosclerosis. 2017 Jun 30. pii: S0021-9150(17)31175.
    PubMed     Text format    


  92. LI C, Liu X, Liu H, Zhao Q, et al
    Bioinformatics analysis in type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta.
    Atherosclerosis. 2017 Jun 10. pii: S0021-9150(17)30274.
    PubMed     Text format    


    May 2017
  93. SHIU SW, Wong Y, Tan KC
    Pre-beta1 HDL in type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:24-28.
    PubMed     Text format     Abstract available


  94. HAGENSEN MK, Mortensen MB, Kjolby M, Stillits NL, et al
    Type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta.
    Atherosclerosis. 2017;263:7-14.
    PubMed     Text format     Abstract available


    March 2017
  95. SANTOS IS, Bittencourt MS, Goulart AC, Schmidt MI, et al
    Insulin resistance is associated with carotid intima-media thickness in non-diabetic subjects. A cross-sectional analysis of the ELSA-Brasil cohort baseline.
    Atherosclerosis. 2017;260:34-40.
    PubMed     Text format     Abstract available


  96. LAMACCHIA O, Fontana A, Pacilli A, Copetti M, et al
    On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;260:20-26.
    PubMed     Text format     Abstract available


    February 2017
  97. FELDMAN DI, Valero-Elizondo J, Salami JA, Rana JS, et al
    Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Atherosclerosis. 2017;258:79-83.
    PubMed     Text format     Abstract available


    January 2017
  98. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
    An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
    Atherosclerosis. 2017;258:40-50.
    PubMed     Text format     Abstract available


  99. MOH MC, Sum CF, Tavintharan S, Ang K, et al
    Baseline predictors of aortic stiffness progression among multi-ethnic Asians with type 2 diabetes.
    Atherosclerosis. 2017;260:102-109.
    PubMed     Text format     Abstract available


    December 2016
  100. LEE DH, Chun EJ, Hur JH, Min SH, et al
    Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
    Atherosclerosis. 2016;257:47-54.
    PubMed     Text format     Abstract available


  101. CHEN J, Zhang J, Yang J, Xu L, et al
    Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Atherosclerosis. 2016;257:152-163.
    PubMed     Text format     Abstract available


  102. SCHOFIELD JD, Steiner R, Liu Y, Hobkirk J, et al
    Sphingolipids and deoxysphingolipids in diabetes.
    Atherosclerosis. 2016;255:4.
    PubMed     Text format    


  103. BANERJEE P, Appleton M, Bowron A, Bartlett K, et al
    Ceramides in diabetes.
    Atherosclerosis. 2016;255:1-2.
    PubMed     Text format    


    November 2016
  104. LANGSTED A, Freiberg JJ, Nordestgaard BG
    Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014.
    Atherosclerosis. 2016;257:9-15.
    PubMed     Text format     Abstract available


  105. SCICALI R, Giral P, Gallo A, Di Pino A, et al
    HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Atherosclerosis. 2016;255:102-108.
    PubMed     Text format     Abstract available


  106. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
    Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
    Atherosclerosis. 2016;255:73-79.
    PubMed     Text format     Abstract available


    September 2016
  107. BERK KA, Vongpromek R, Jiang M, Schneider WJ, et al
    Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Atherosclerosis. 2016;254:67-72.
    PubMed     Text format     Abstract available


  108. AFARIDEH M, Aryan Z, Ghajar A, Noshad S, et al
    Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
    Atherosclerosis. 2016;254:42-51.
    PubMed     Text format     Abstract available


    August 2016
  109. KIANOUSH S, Blaha MJ
    Early interventions for optimal control of prediabetes and diabetes: Critical to prevent cardiovascular disease?
    Atherosclerosis. 2016 Aug 28. pii: S0021-9150(16)31307.
    PubMed     Text format    


  110. HEFFERNAN KS
    Carotid artery stiffness and cognitive function in adults with and without type 2 diabetes: Extracranial contribution to an intracranial problem?
    Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31297.
    PubMed     Text format    


  111. FIORENTINO TV, Sesti F, Andreozzi F, Pedace E, et al
    One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden.
    Atherosclerosis. 2016;253:61-69.
    PubMed     Text format     Abstract available


  112. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
    Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Atherosclerosis. 2016;253:1-6.
    PubMed     Text format     Abstract available


    July 2016
  113. GEIJSELAERS SL, Sep SJ, Schram MT, van Boxtel MP, et al
    Carotid stiffness is associated with impairment of cognitive performance in individuals with and without type 2 diabetes. The Maastricht Study.
    Atherosclerosis. 2016 Jul 22. pii: S0021-9150(16)31213.
    PubMed     Text format     Abstract available


  114. WYCHERLEY TP, Thompson CH, Buckley JD, Luscombe-Marsh ND, et al
    Long-term effects of weight loss with a very-low carbohydrate, low saturated fat diet on flow mediated dilatation in patients with type 2 diabetes: A randomised controlled trial.
    Atherosclerosis. 2016;252:28-31.
    PubMed     Text format     Abstract available


  115. THEN C, Rottenkolber M, Lechner A, Meisinger C, et al
    Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Atherosclerosis. 2016;252:88-96.
    PubMed     Text format     Abstract available


    June 2016
  116. BEN NASR M, Fiorina P
    CXCR4 antagonism overcomes diabetic stem cell mobilopathy.
    Atherosclerosis. 2016 Jun 23. pii: S0021-9150(16)30268.
    PubMed     Text format    


  117. BORRADAILE N, Le Goff W
    Lipidomic approach provides new clues toward solving the mystery of accelerated atherosclerosis in diabetes.
    Atherosclerosis. 2016 Jun 11. pii: S0021-9150(16)30247.
    PubMed     Text format    


    May 2016
  118. CAPPELLARI R, D'Anna M, Avogaro A, Fadini GP, et al
    Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
    Atherosclerosis. 2016 May 20. pii: S0021-9150(16)30205.
    PubMed     Text format     Abstract available


  119. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
    Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
    Atherosclerosis. 2016;250:114-121.
    PubMed     Text format     Abstract available


  120. MENEGAUT L, Masson D, Abello N, Denimal D, et al
    Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
    PubMed     Text format     Abstract available


  121. KIEC-WILK B, Matejko B, Razny U, Stankiewicz M, et al
    Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus.
    Atherosclerosis. 2016 May 3. pii: S0021-9150(16)30162.
    PubMed     Text format     Abstract available


  122. ARONER SA, St-Jules DE, Mukamal KJ, Katz R, et al
    Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2016;248:224-9.
    PubMed     Text format     Abstract available


  123. KIM SA, Park SH, Jo SH, Park KH, et al
    Alterations of carotid arterial mechanics preceding the wall thickening in patients with hypertension.
    Atherosclerosis. 2016;248:84-90.
    PubMed     Text format     Abstract available


  124. PAN L, Yang Z, Wu Y, Yin RX, et al
    The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
    Atherosclerosis. 2016;248:2-9.
    PubMed     Text format     Abstract available


    April 2016
  125. ORTEGA MORENO L, Lamacchia O, Fontana A, Copetti M, et al
    The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.
    Atherosclerosis. 2016;250:23-29.
    PubMed     Text format     Abstract available


  126. LANDMAN GW, Kleefstra N, Groenier KH, Bakker SJ, et al
    Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Atherosclerosis. 2016;250:46-51.
    PubMed     Text format     Abstract available


  127. WILLIAMS KJ, Wu X
    Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.
    Atherosclerosis. 2016;247:225-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: